Companies
Revvity
Medical devicesWaltham, MassachusettsRVTYAbout 11,000 employees
More about Revvity
Life sciences and diagnostics company selling lab instruments, reagents, software and newborn and immunodiagnostic tests to researchers and clinical labs
Revenue
$2.86B
Fiscal 2025, up about 4%
Employees
About 11,000
As of December 2025
Stock
RVTY
New York Stock Exchange
Headquarters
Waltham, Massachusetts
CEO
Prahlad Singh
Since January 2020
Main businessesLife Sciences, Diagnostics
Current strategyIncreasing investment as customer demand recovers, while agreeing in 2026 to divest its China immunodiagnostics business
Recent workforce changesMore than 100 Massachusetts jobs cut in September and October 2025 as Boston and Lawrence sites were consolidated into Hopkinton
CompetitorsThermo Fisher Scientific, Danaher, Agilent Technologies
Related companiesThermo Fisher ScientificDanaherAgilent Technologies
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), boston.com
No source-backed updates for Revvity yet. They appear here when a public report or filing covers the company.
No one has posted about Revvity yet. Be the first to post ›
Follow Revvity in a feed reader, no account needed: RSS feed